332 related articles for article (PubMed ID: 31113430)
1. Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
Liu L; Zhang X; Liu Y; Zhang L; Zheng J; Wang J; Hansbro PM; Wang L; Wang G; Hsu AC
Respir Res; 2019 May; 20(1):95. PubMed ID: 31113430
[TBL] [Abstract][Full Text] [Related]
2. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1.
Hinks TSC; Brown T; Lau LCK; Rupani H; Barber C; Elliott S; Ward JA; Ono J; Ohta S; Izuhara K; Djukanović R; Kurukulaaratchy RJ; Chauhan A; Howarth PH
J Allergy Clin Immunol; 2016 Jul; 138(1):61-75. PubMed ID: 26851968
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.
Lai T; Chen M; Deng Z; L Y; Wu D; Li D; Wu B
BMC Pulm Med; 2015 Jan; 15():1. PubMed ID: 25578181
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of asthma subgroups associated with circulating YKL-40 levels.
Gomez JL; Yan X; Holm CT; Grant N; Liu Q; Cohn L; Nezgovorova V; Meyers DA; Bleecker ER; Crisafi GM; Jarjour NN; Rogers L; Reibman J; Chupp GL;
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29025889
[TBL] [Abstract][Full Text] [Related]
6. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
7. YKL-40 protein correlates with the phenotype of asthma.
Specjalski K; Chełmińska M; Jassem E
Lung; 2015 Apr; 193(2):189-94. PubMed ID: 25663327
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β.
Gao P; Gibson PG; Baines KJ; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Zhang J; Simpson JL
Respir Res; 2015 Jan; 16(1):5. PubMed ID: 25616863
[TBL] [Abstract][Full Text] [Related]
9. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
[TBL] [Abstract][Full Text] [Related]
11. YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma.
Lee JH; Park KH; Park JW; Hong CS
J Investig Allergol Clin Immunol; 2012; 22(7):501-7. PubMed ID: 23397672
[TBL] [Abstract][Full Text] [Related]
12. CHI3L1 polymorphisms, cord blood YKL-40 levels and later asthma development.
Usemann J; Frey U; Mack I; Schmidt A; Gorlanova O; Röösli M; Hartl D; Latzin P
BMC Pulm Med; 2016 May; 16(1):81. PubMed ID: 27193312
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptom-associated IL-1β and TNF-α release correlates with impaired bronchodilator response and neutrophilic airway inflammation in asthma.
Zhang L; Zhang X; Zheng J; Liu Y; Wang J; Wang G; Zhang HP; Kang Y; Peng ZG; Ji YL; Wang L; Gibson PG; Wang G
Clin Exp Allergy; 2019 Jun; 49(6):770-780. PubMed ID: 30675924
[TBL] [Abstract][Full Text] [Related]
15. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes.
Baines KJ; Simpson JL; Wood LG; Scott RJ; Fibbens NL; Powell H; Cowan DC; Taylor DR; Cowan JO; Gibson PG
J Allergy Clin Immunol; 2014 Apr; 133(4):997-1007. PubMed ID: 24582314
[TBL] [Abstract][Full Text] [Related]
16. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.
Tang H; Fang Z; Sun Y; Li B; Shi Z; Chen J; Zhang T; Xiu Q
Eur Respir J; 2010 Apr; 35(4):757-60. PubMed ID: 20356987
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Serum YKL-40 by Real-Time Surface Plasmon Resonance Technology in North-Indian Asthma Patients.
Naglot S; Aggarwal P; Dey S; Dalal K
J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27616735
[TBL] [Abstract][Full Text] [Related]
18. A chitinase-like protein in the lung and circulation of patients with severe asthma.
Chupp GL; Lee CG; Jarjour N; Shim YM; Holm CT; He S; Dziura JD; Reed J; Coyle AJ; Kiener P; Cullen M; Grandsaigne M; Dombret MC; Aubier M; Pretolani M; Elias JA
N Engl J Med; 2007 Nov; 357(20):2016-27. PubMed ID: 18003958
[TBL] [Abstract][Full Text] [Related]
19. The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children.
Santos CB; Davidson J; Covar RA; Spahn JD
Ann Allergy Asthma Immunol; 2014 Sep; 113(3):263-6. PubMed ID: 24954373
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal assessment of circulating YKL-40 levels in preschool children with wheeze.
James A; Stenberg Hammar K; Reinius L; Konradsen JR; Dahlén SE; Söderhäll C; Hedlin G
Pediatr Allergy Immunol; 2017 Feb; 28(1):79-85. PubMed ID: 27732738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
